Skip to main content
. 2018 Dec 17;13(12):e0209327. doi: 10.1371/journal.pone.0209327

Fig 2. Changes in lactate levels over time, according to outcomes.

Fig 2

Serum lactate levels significantly decreased over time. (A) Changes in lactate levels between the neuromuscular blockade (NMB) and placebo groups. Lactate levels were not different between the NMB and placebo groups (p = 0.565). (B) Changes in lactate levels in survivors and non-survivors. Survivors had a significantly lower serum lactate level (p = 0.047). However, post hoc analyses showed that there were no differences in the serum lactate levels at each time-point, between survivors and non-survivors. Numbers are included number of patients for analyses.